Surfactant and partial liquid ventilation via conventional and high-frequency techniques in an animal model of respiratory distress syndrome
- 1 July 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 1 (1) , 72-78
- https://doi.org/10.1097/00130478-200007000-00014
Abstract
To compare the physiologic and pathologic effects of conventional ventilation (CV) and high-frequency ventilation (HFV) during partial liquid ventilation (PLV) with perflubron after surfactant treatment with the results of HFV plus surfactant in an animal lung-injury model created by saline lavage. We also studied the dose effects of perflubron during HFV. Randomized experimental study. Research animal laboratory. A total of 32 newborn piglets. After lung injury was induced, the animals were randomized to one of four groups: a) CV + surfactant + perflubron to functional residual capacity (FRC); b) HFV + surfactant + perflubron to FRC; c) HFV + surfactant + 10 mL/kg perflubron; and d) HFV + surfactant. All then received intratracheal surfactant. After 30 mins, perflubron was administered to the PLV groups. The animals underwent ventilation for 20 hrs. Arterial blood gases and hemodynamic variables were continuously monitored. Pulmonary histologic and morphometric analyses were performed after death or euthanasia at 20 hrs. All animals had sustained improvements in arterial/alveolar oxygen ratios, and no differences were observed among groups. All HFV groups required higher mean airway pressures to maintain oxygenation (p < .05). Hemodynamics did not differ among groups. Pathologic analysis demonstrated decreased lung injury in both cranial-dorsal (nondependent) and caudal-ventral (dependent) lobes of all animals treated with PLV when compared with those treated with HFV + surfactant (p < .05). After surfactant treatment, physiologic support over 20 hrs was similar during HFV with or without perflubron and CV with perflubron. All PLV modalities improved lung pathologic factors uniformly to a greater degree than did HFV + surfactant. A lower treatment volume of perflubron during HFV produced physiologic and pathologic results similar to those produced by perflubron with respect to FRC during either CV or HFV.Keywords
This publication has 24 references indexed in Scilit:
- Exogenous Surfactant and Partial Liquid VentilationAmerican Journal of Respiratory and Critical Care Medicine, 1997
- Perfluorocarbon-associated gas exchange in normal and acid-injured large sheepCritical Care Medicine, 1996
- Evaluation of lung function after intratracheal perfluorocarbon administration in healthy animalsCritical Care Medicine, 1996
- Double-blind, randomized trial of one versus three prophylactic doses of synthetic surfactant in 826 neonates weighing 700 to 1100 grams: Effects on mortality rateThe Journal of Pediatrics, 1995
- Health and neurodevelopmental outcome at 1-year adjusted age in 508 infants weighing 700 to 1100 grams who received prophylaxis with one versus three doses of synthetic surfactantThe Journal of Pediatrics, 1995
- One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placeboThe Journal of Pediatrics, 1995
- Survival and follow-up of infants born at 23 to 26 weeks of gestational age: Effects of surfactant therapyThe Journal of Pediatrics, 1994
- Intratracheal perfluorocarbon administration combined with mechanical ventilation in experimental respiratory distress syndromeCritical Care Medicine, 1993
- Perfluorocarbon-associated gas exchangeCritical Care Medicine, 1991
- Effect of High-frequency Ventilation on the Development of Alveolar Edema in Premature Monkeys at Risk for Hyaline Membrane DiseaseAmerican Review of Respiratory Disease, 1991